Will Placement On China's New Essential Drugs List Bring Boon Or Bane? Pharma Execs Debate The Issue
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Senior leaders at pharmaceutical outfits across China and the globe are awaiting China's issuing of its new streamlined Essential Drugs List, some with wonder and some with trepidation
You may also be interested in...
Powerful Chinese Government Commission Set To Issue Price Caps For Essential Drug List Medicines
BEIJING - China's powerful National Development and Reform Commission, which has a virtually unrestricted purview over setting prices for medicines that are included on the country's Essential Drug List, is in the final stages of determining caps for every item on the newly revised list
Powerful Chinese Government Commission Set To Issue Price Caps For Essential Drug List Medicines
BEIJING - China's powerful National Development and Reform Commission, which has a virtually unrestricted purview over setting prices for medicines that are included on the country's Essential Drug List, is in the final stages of determining caps for every item on the newly revised list
China Paring Down Essential Medicines List In Sweeping Health System Reforms
[Editor's note: This is part three in a new series on China's wide-ranging plans to reform the country's health system, including its hospitals, insurance schemes, and access to medicines. Part one in the series appeared in PharmAsia News Oct. 30, 2008, and part two appeared Nov. 13, 2008.]